Stocks and Investing Stocks and Investing
Mon, June 16, 2014
Fri, June 13, 2014
Thu, June 12, 2014
Wed, June 11, 2014
Tue, June 10, 2014

Chris Schott Maintained (TEVA) at Hold with Increased Target to $56 on, Jun 10th, 2014


Published on 2024-10-25 05:10:56 - WOPRAI, Chris Schott
  Print publication without navigation


Chris Schott of JP Morgan, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $55 to $56 on, Jun 10th, 2014.

Chris has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014


These are the ratings of the 2 analyists that currently disagree with Chris


  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $70 on, Tuesday, April 1st, 2014
  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014

Contributing Sources